Abstract CT227: Interim Results of a Phase 1b/2 Study of ADG126 (a Masked Anti-Ctla-4 SAFEbody®) Monotherapy and in Combination with Toripalimab (an Anti-Pd-1 Antibody) in Patients (pts) with Advanced/metastatic Solid Tumors
Cancer Research(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要